Search

Your search keyword '"N Di Muzio"' showing total 204 results
Start Over Author "N Di Muzio" Topic oncology
204 results on '"N Di Muzio"'

1. PD-0415 Pelvic RT in prostate cancer: late intestinal toxicity is modulated by severity of acute symptoms

Author

A. Gebbia, F. Munoz, A. Magli, D. Cante, E. Garibaldi, B. Noris Chiorda, G. Girelli, E. Villa, A. Faiella, J.M. Waskiewicz, B. Avuzzi, A. Pastorino, E. Moretti, L. Rago, A. Bresolin, C. Bianconi, F. Badenchini, T. Rancati, R. Valdagni, V. Vavassori, M. Gatti, G. Sanguineti, N. Di Muzio, C. Fiorino, and C. Cozzarini

Subjects
Oncology, Radiology, Nuclear Medicine and imaging, Hematology
Published
2022
Full Text
View/download PDF

3. PO-1139 Skin toxicity in 1325 breast cancer patients treated with hypofractionated RT without boost

Author

Chiara Brombin, Chiara Lucrezia Deantoni, Paola Mangili, Lucia Perna, A. Del Vecchio, Pier Giorgio Esposito, A.M. Deli, M.S. Di Serio, N. Di Muzio, Anna Chiara, A. Sanchez Galvan, Sara Broggi, Roberta Castriconi, Italo Dell'Oca, Paola M.V. Rancoita, R. Tummineri, Flavia Zerbetto, M. Pasetti, Andrei Fodor, Claudio Fiorino, and Barbara Longobardi

Subjects
Oncology, medicine.medical_specialty, Breast cancer, Skin toxicity, business.industry, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, Hematology, business, medicine.disease
Published
2021
Full Text
View/download PDF

4. PO-1342 Trends and predictors of worsening at RT end of anxiety and depression during RT for prostate cancer

Author

A. Bresolin, Elisabetta Garibaldi, E. Olivetta, Alessandro Magli, A. Faiella, Cristina Piva, P. Ferrari, Fabio Badenchini, Marco Gatti, N. Di Muzio, Giuseppe Sanguineti, Tiziana Rancati, Eugenio Villa, Barbara Avuzzi, Domenico Cante, Fernando Munoz, L. Ferella, Giuseppe Girelli, V. Vavassori, Claudio Fiorino, Cesare Cozzarini, J.M. Waskiewicz, Riccardo Valdagni, E. Moretti, and B. Noris Chiorda

Subjects
Oncology, medicine.medical_specialty, business.industry, Hematology, medicine.disease, Prostate cancer, Internal medicine, medicine, Anxiety, Radiology, Nuclear Medicine and imaging, medicine.symptom, business, Depression (differential diagnoses)
Published
2021
Full Text
View/download PDF

5. PD-0769 Patient-reported acute intestinal toxicity and impact on patient QoL after WPRT for prostate cancer

Author

Giuseppe Girelli, Cristina Piva, L. Ferella, Domenico Cante, Barbara Avuzzi, Riccardo Valdagni, E. Moretti, Alessandro Magli, J.M. Waskiewicz, A. Pastorino, Marco Gatti, A. Bresolin, Claudio Fiorino, N. Di Muzio, Tiziana Rancati, Eugenio Villa, B. Noris Chiorda, Giuseppe Sanguineti, Cesare Cozzarini, B. Farina, A. Faiella, V. Vavassori, Fabio Badenchini, P. Ferrari, and Fernando Munoz

Subjects
Oncology, medicine.medical_specialty, Prostate cancer, business.industry, Intestinal toxicity, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, Hematology, business, medicine.disease
Published
2021
Full Text
View/download PDF

6. PH-0660 Independent role of dose-escalation and prophylactic WPRT in salvage RT after radical prostatectomy

Author

B. Noris Chiorda, Chiara Lucrezia Deantoni, A. Briganti, E. Olivetta, Andrei Fodor, Claudio Fiorino, Cristina Piva, Alessandro Magli, N. Fossati, A. Pastorino, Giuseppe Sanguineti, F. Montorsi, G. Gandaglia, Barbara Avuzzi, A. Faiella, Domenico Cante, Riccardo Valdagni, N. Di Muzio, Fernando Munoz, Cesare Cozzarini, S. Marco Andrea, and L. Ferella

Subjects
medicine.medical_specialty, Oncology, Prostatectomy, business.industry, medicine.medical_treatment, medicine, Dose escalation, Urology, Radiology, Nuclear Medicine and imaging, Hematology, business
Published
2021
Full Text
View/download PDF

7. Toxicity of Hypofractionated Whole Breast Radiotherapy Without Boost and Timescale of Late Skin Responses in a Large Cohort of Early-Stage Breast Cancer Patients

Author

Roberta Castriconi, Barbara Longobardi, Pier Giorgio Esposito, Ariadna Sanchez Galvan, Antonella del Vecchio, N. Di Muzio, Mariaclelia Stefania Di Serio, Paola M.V. Rancoita, A.M. Deli, Chiara Brombin, Paola Mangili, Andrei Fodor, Claudio Fiorino, Chiara Lucrezia Deantoni, Marcella Pasetti, Italo Dell'Oca, R. Tummineri, and Flavia Zerbetto

Subjects
Oncology, Cancer Research, medicine.medical_specialty, business.industry, Breast Neoplasms, Middle Aged, medicine.disease, Mastectomy, Segmental, Whole breast radiotherapy, Large cohort, Cohort Studies, Breast cancer, Internal medicine, Toxicity, Medicine, Humans, Female, Radiation Dose Hypofractionation, Radiotherapy, Adjuvant, Stage (cooking), business
Abstract

To report toxicity of hypofractionated whole-breast radiotherapy in a large cohort of early-stage breast cancer (BCaients.From 02/2009-05/2017, 1325 consecutive BCa patients were treated with 40.05 Gy/15 fractions, without boost. Median age was 62 (IQR:51.1-70.5) years. Chemotherapy was prescribed for 28% of patients, hormonal therapy for 80.3%, monoclonal antibodies for 8.2%.Median follow-up was 72.4 (IQR: 44.6-104.1) months. Acute RTOG toxicity was: 69.8% Grade (G) 1, 14.3% G2 and 1.7% G3. Late SOMA-LENT toxicities were: edema-hyperpigmentation (E-H): G1 28.67%, G2 4.41%, G3 0.15%; fibrosis-atrophy-telangiectasia-pain (F-A-T-P): G1 14.6%, G2 3.2%, G3 0.8%, G4 0.1%. Median time to first occurrence was 6 and 18 months, respectively. Aesthetic result after surgery was excellent in 28.7%, good in 41.5%, acceptable in 20.3% and poor in 9.5% of patients. Change in breast appearance after radiotherapy was mild in 6.9%, moderate in 2.3% and marked in 1.3% of patients. Concomitant chemotherapy, obesity, smoking, use of bolus and planning target volume (PTV) were associated with higher acute toxicity. Patients ≥55 years old were less likely to experience acute toxicity. PTV and acute G2 toxicity were associated with ≥G2 E-H. PTV, concomitant chemotherapy, hypertension and ≥G2 acute toxicity were associated with increased risk of F-A-T-P.Hypofractionated whole-breast radiotherapy without boost demonstrated mild acute and late toxicity in a large cohort of consecutive patients. Moderate and marked changes in breast appearance were registered for 3.6% of patients and occurred between 18 to 42 months.

Published
2021

8. PD-0414 Trend over time of patient-reported QoL domains after pelvic nodal irradiation for prostate cancer

Author

A. Faiella, A. Gebbia, E. Villa, J.M. Waskiewicz, A. Magli, B. Avuzzi, E. Garibaldi, D. Cante, G. Girelli, M. Gatti, L. Ferella, B. Noris Chiorda, L. Rago, P. Ferrari, A. Bresolin, C. Piva, F. Badenchini, T. Rancati, R. Valdagni, V. Vavassori, F. Munoz, G. Sanguineti, N. Di Muzio, C. Fiorino, and C. Cozzarini

Subjects
Oncology, Radiology, Nuclear Medicine and imaging, Hematology
Published
2022
Full Text
View/download PDF

13. A Multicenter Large Retrospective Database on the Personalization of Stereotactic Ablative Radiotherapy for Lung Metastases From Colon-Rectal Cancer: The LaIT-SABR Study

Author

Davide Franceschini, Stefano Maria Magrini, Sara Ramella, Vieri Scotti, F. Casamassima, L. Frassinelli, Frank Lohr, Luigi Corti, N. Di Muzio, Claudia Sangalli, I. Fazio, F. Perrone, M. Perna, Stefano Arcangeli, R.M. Niespolo, D. Aiello, Lorenzo Livi, Francesco Pasqualetti, Marta Scorsetti, M. Franceschini, G. Mortellaro, M.F. Osti, B. De Bari, A. Ravasio, Riccardo Valdagni, M. Sepulcri, Silvia Chiesa, Ernesto Maranzano, V. Valentini, A. Di Marzo, F.M. Aquilanti, Fabiola Paiar, Alessio Bruni, Andrei Fodor, Paolo Borghetti, A. Iurato, Filippo Alongi, Michele Rigo, Marianna Alessandra Gerardi, Giampaolo Montesi, Luca Nicosia, L. Vavassori, Rosario Mazzola, Barbara Alicja Jereczek-Fossa, Nicosia, L, Franceschini, D, Perrone, F, Casamassima, F, Gerardi, M, Perna, M, Scotti, V, Fodor, A, Mazzola, R, Rigo, M, Iurato, A, Pasqualetti, F, Chiesa, S, Niespolo, R, Bruni, A, Frassinelli, L, Borghetti, P, Marzo, A, Ravasio, A, De Bari, B, Sepulcri, M, Aiello, D, Mortellaro, G, Sangalli, C, Franceschini, M, Montesi, G, Aquilanti, F, Valdagni, R, Fazio, I, Corti, L, Vavassori, L, Maranzano, E, Magrini, S, Lohr, F, Arcangeli, S, Valentini, V, Paiar, F, Ramella, S, Di Muzio, N, Livi, L, Jereczek-Fossa, B, Osti, M, Scorsetti, M, and Alongi, F

Subjects
Cancer Research, Univariate analysis, medicine.medical_specialty, Radiation, Predictive marker, Colorectal cancer, business.industry, medicine.medical_treatment, medicine.disease_cause, medicine.disease, SABR volatility model, Primary tumor, Radiation therapy, Lesion, colorectal metastase, Oncology, medicine, Radiology, Nuclear Medicine and imaging, KRAS, Radiology, oligometastase, medicine.symptom, business, SABR
Abstract

PURPOSE/OBJECTIVE(S): stereotactic ablative radiotherapy (SABR) has been shown to increase survival rates in oligometastatic disease (OMD), but local control of colorectal metastases still remains poor. We aimed to identify potential predictive factors of SBRT response through a multicenter large retrospective database and to investigate how lung SBRT can impact on the progression to the polymetastatic disease (PMD). MATERIALS/METHODS: the study involved 22 centers, and was approved by the Ethical Committee (Prot. Negrar 2019-ZT). 1023 lung metastases treated with SBRT in 622 patients were reported. The median BED was 105 Gy10. Lesion diameter GTV, PTV volume, dose, fractionations, and site of primary tumor were evaluated as potential predictive marker for SBRT response for the primary end-point local progression-free survival (LPFS). EGFR, KRAS, NRAS, BRAF, and MSI were also evaluated. Secondary end-point was the time to the polymetastatic conversion (ttPMC). RESULTS: the median follow-up was 26 months (range 3-117 months). The median lesion diameter was 13 mm (range 4-58 mm). The 2- and 3-year LPFS were 75.6% and 71%, respectively. At the univariate analysis, BED ≥125Gy10 was associated with improved LPFS (2-year: 94.1% versus 72.6%; P = < 0.0001), single fraction SBRT correlated with better LPFS in the overall population (2-year: 80.6% versus 73.7%; P = 0.03), but no significant difference was observed when considering the population treated with BED > 100 Gy10. Lesion diameter ≤19 mm correlated with improved LPFS (2-year 80% versus 60%; P = < 0.0001). The median ttPMC was 26 months, and the 2-year ttPMC was 54.5%. The median PFS was 11.3 months. After SABR, 36% patients had polymetastatic relapse, 39.5% patients had an oligometastatic relapse, and 24.5% patients had no further relapse. CONCLUSION: the present is the largest series of lung colorectal metastases treated with SABR. The results support the use of SBRT in lung oligometastatic colorectal cancer patients as it might delay the transition to PMD or offer relatively long disease-free period in selected cases. Several biological and clinical predictive factors were identified to assure the highest local control, on the basis of which a decisional algorithm will be derived.

Published
2021
Full Text
View/download PDF

14. What is the optimal duration of hormonal treatment during salvage radiotherapy in men with pN1 prostate cancer? Results form a large multi-institutional series

Author

S.F. Shariat, B. Noris Chiorda, Gregor Goldner, S. Joniau, H. Van Poppel, Elio Mazzone, Cesare Cozzarini, Charlien Berghen, Stephen A. Boorjian, N. Di Muzio, Vito Cucchiara, Robert Jeffrey Karnes, G. Gandaglia, Giovanni Motterle, T. Kumar, N. Fossati, Armando Stabile, Daniele Robesti, F. Montorsi, G. De Meerleer, A. Briganti, Detlef Bartkowiak, Thomas Wiegel, and Alberto Bossi

Subjects
Oncology, medicine.medical_specialty, Series (stratigraphy), business.industry, Internal medicine, Salvage radiotherapy, PN1 Prostate Cancer, Urology, medicine, Duration (project management), business, Hormone
Published
2021
Full Text
View/download PDF

15. Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy

Author

Luca Marinelli, Giulio Francolini, Stefano Maria Magrini, Daniela Musio, Maurizio Valeriani, Alessio Bruni, Beatrice Detti, Ernesto Maranzano, Saverio Caini, Cynthia Aristei, N. Di Muzio, Andrei Fodor, Andrea Lancia, Simona Borghesi, Gianluca Ingrosso, D. Russo, Fabio Trippa, Lorenzo Livi, Luca Triggiani, Ingrosso, G., Detti, B., Fodor, A., Caini, S., Borghesi, S., Triggiani, L., Trippa, F., Russo, D., Bruni, A., Francolini, G., Lancia, A., Marinelli, L., Di Muzio, N., Livi, L., Magrini, S. M., Maranzano, E., Musio, D., Aristei, C., and Valeriani, M.

Subjects
Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Oligoprogression, medicine.drug_class, Stereotactic body radiotherapy, medicine.medical_treatment, Kaplan-Meier Estimate, Radiosurgery, Targeted therapy, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Internal medicine, Androgen Receptor Antagonists, medicine, Humans, Molecular Targeted Therapy, Survival analysis, Androgen receptor-targeted therapy, Aged, Retrospective Studies, Analysis of Variance, business.industry, Metastatic castration-resistant prostate cancer, NEST-free survival, Hazard ratio, Radiotherapy Dosage, Common Terminology Criteria for Adverse Events, General Medicine, Middle Aged, Androgen, medicine.disease, Combined Modality Therapy, Progression-Free Survival, Radiation therapy, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, Toxicity, Disease Progression, business
Abstract

Objectives: To report outcomes of stereotactic body radiotherapy (SBRT) in metastatic castration-resistant prostate cancer (mCRPC) patients with oligoprogression (≤ 5 metastases) during first-line treatment with androgen receptor-targeted therapy (ARTT). Patients and methods: Retrospective multi-institutional analysis of mCRPC patients treated with SBRT to oligoprogressive lesions during ARTT. End-points were time to next-line systemic treatment (NEST), radiological progression-free survival (r-PFS) and overall survival (OS). Toxicity was registered according to Common Terminology Criteria for Adverse Events (CTCAE) v4.0. Survival analysis was performed using the Kaplan–Meier method, univariate and multivariate analysis (MVA) were performed. Results: Data from 34 patients were analyzed. Median NEST-free survival, r-PFS, and OS were 16.97, 13.47, and 38.3months, respectively. At MVA, factors associated with worse NEST-free survival and r-PFS were polymetastatic burden at diagnosis of metastatic hormone-sensitive disease (hazard ratio [HR] 3.66, p = 0.009; HR 3.03, p = 0.034), PSA ≤ 7ng/ml at mCRPC diagnosis (HR 0.23, p = 0.017; HR 0.19, p = 0.006) and PSADT ≤ 3months at mCRPC diagnosis (HR 3.39, p = 0.026; HR 2.79, p = 0.037). Polymetastatic state at mHSPC diagnosis was associated with a decreased OS (HR 4.68, p = 0.029). No patient developed acute or late grade ≥ 2 toxicity. Conclusion: Our results suggest that SBRT in oligoprogressive mCPRC is safe, effective and seems to prolong the efficacy of the ongoing systemic treatment positively affecting disease progression. Prospective trials are needed.

Published
2021

17. PO-1345 Symptoms affecting Emotional, Systemic and Social Domains 2 years after RT for prostate cancer

Author

Eugenio Villa, A. Pastorino, Cristina Piva, J.M. Waskiewicz, Riccardo Valdagni, Giuseppe Sanguineti, Giuseppe Girelli, A. Bresolin, B. Noris Chiorda, V. Vavassori, L. Ferella, Alessandro Magli, Domenico Cante, Tiziana Rancati, P. Ferrari, Elisabetta Garibaldi, E. Olivetta, A. Faiella, N. Di Muzio, Barbara Avuzzi, Claudio Fiorino, Angelo Maggio, Cesare Cozzarini, Fabio Badenchini, Fernando Munoz, and Marco Gatti

Subjects
Oncology, medicine.medical_specialty, Prostate cancer, business.industry, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, Hematology, medicine.disease, business
Published
2021
Full Text
View/download PDF

18. PO-1354 Time Dependence of PSADT prognostic threshold in men treated with post-prostatectomy salvage RT

Author

E. Olivetta, Cristina Piva, L. Andreoli, A. Faiella, B. Noris Chiorda, A. Pastorino, Riccardo Valdagni, F. Montorsi, N. Di Muzio, Cesare Cozzarini, F. Tonetto, Giuseppe Sanguineti, Flavia Zerbetto, Andrei Fodor, Claudio Fiorino, N. Fossati, Barbara Avuzzi, Chiara Lucrezia Deantoni, Domenico Cante, A. Briganti, G. Gandaglia, and Alessandro Magli

Subjects
medicine.medical_specialty, Oncology, business.industry, Urology, Medicine, Radiology, Nuclear Medicine and imaging, Hematology, business, Post prostatectomy
Published
2021
Full Text
View/download PDF

19. PO-1025 Outcomes of re-irradiation of relapsed intracranic lesions with stereotactic radiotherapy

Author

N. Di Muzio, Sergio Villa, Andrei Fodor, A.M. Deli, Sara Broggi, A. Sanchez Galvan, Flavia Zerbetto, S. Baroni, A. Del Vecchio, G. Mandurino, R. Tummineri, P. Pacifico, and Chiara Lucrezia Deantoni

Subjects
Re-Irradiation, Stereotactic radiotherapy, Oncology, business.industry, Medicine, Radiology, Nuclear Medicine and imaging, Hematology, business, Nuclear medicine
Published
2021
Full Text
View/download PDF

20. PO-1214 Toxicity profile of adjuvant hypofractionated Image-Guided Radiotherapy in biliary tract carcinoma

Author

Najla Slim, P. Pacifico, A.M. Deli, Stefano Cascinu, F. De Cobelli, L. Aldrighetti, Paolo Passoni, N. Di Muzio, A. Casadei Gardini, Monica Ronzoni, R. Tummineri, Claudio Fiorino, and F. Pedica

Subjects
medicine.medical_specialty, Oncology, business.industry, medicine.medical_treatment, medicine, Radiology, Nuclear Medicine and imaging, Hematology, Radiology, Image guided radiotherapy, business, Biliary tract carcinoma, Adjuvant, Toxicity profile
Published
2021
Full Text
View/download PDF

21. PO-1225 Hypofractionated radiotherapy after induction chemotherapy for advanced pancreatic cancer

Author

Gianpaolo Balzano, A. Del Vecchio, Renato Castoldi, Michele Reni, Stefano Cascinu, Giulia Orsi, N. Di Muzio, Massimo Falconi, Najla Slim, M. Macchini, Barbara Longobardi, Sara Broggi, U. Peretti, M. Mori, Paolo Passoni, Claudio Fiorino, and Giovanni Mauro Cattaneo

Subjects
Oncology, Hypofractionated Radiotherapy, medicine.medical_specialty, business.industry, Pancreatic cancer, Internal medicine, Medicine, Induction chemotherapy, Radiology, Nuclear Medicine and imaging, Hematology, business, medicine.disease
Published
2021
Full Text
View/download PDF

22. PO-1307 Extended nodal radiotherapy for relapsed gynecologic tumors with PET/CT-guided SIB

Author

Flavia Zerbetto, Chiara Lucrezia Deantoni, Paola Mangili, S. Baroni, Sergio Villa, A. Del Vecchio, A. Sanchez Galvan, G. Mandurina, R. Tummineri, N. Di Muzio, Stefano Arcangeli, P. Pacifico, and Andrei Fodor

Subjects
Radiation therapy, PET-CT, Oncology, business.industry, medicine.medical_treatment, medicine, Radiology, Nuclear Medicine and imaging, Hematology, NODAL, business, Nuclear medicine
Published
2021
Full Text
View/download PDF

23. PH-0112 Multicenter large retrospectIve database on SBRT for colorectal lung metastases: the LaIT-SABR study

Author

Riccardo Valdagni, L. Vavassori, Michele Rigo, Marianna Alessandra Gerardi, B. De Bari, N. Di Muzio, Barbara Alicja Jereczek-Fossa, Vieri Scotti, Frank Lohr, M. Perna, Filippo Alongi, Luigi Corti, I. Fazio, R.M. Niespolo, G. Mortellaro, F.M. Aquilanti, Andrei Fodor, Paolo Borghetti, M.F. Osti, Luca Nicosia, A. Ravasio, Davide Franceschini, L. Frassinelli, A. Di Marzo, G. Gadducci, A. Iurato, Fabiola Paiar, D. Aiello, Alessio Bruni, F. Casamassima, Sara Ramella, Silvia Chiesa, Rosario Mazzola, F. Perrone Congedi, Stefano Arcangeli, Stefano Maria Magrini, M. Franceschini, Lorenzo Livi, M. Sepulcri, Francesco Pasqualetti, Claudia Sangalli, Marta Scorsetti, Ernesto Maranzano, Giampaolo Montesi, and V. Valentini

Subjects
medicine.medical_specialty, Lung, medicine.anatomical_structure, Oncology, business.industry, Medicine, Radiology, Nuclear Medicine and imaging, Hematology, Radiology, business, SABR volatility model, Retrospective database
Published
2021
Full Text
View/download PDF

24. PO-1401 Lung metastasis from renal cell carcinoma: SBRT alone or in association with target therapy as a potential treatment option

Author

Flavia Zerbetto, Chiara Lucrezia Deantoni, T. Roberta, Sara Broggi, N. Di Muzio, M. Pasetti, S. Foti, and Anna Chiara

Subjects
Oncology, medicine.medical_specialty, business.industry, Lung metastasis, Treatment options, Hematology, medicine.disease, Renal cell carcinoma, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, Target therapy, business
Published
2021
Full Text
View/download PDF

25. PD-0767 Predictors of urinary incontinence 2 years after RT with different intents for prostate cancer

Author

Fabio Badenchini, J.M. Waskiewicz, Eugenio Villa, Riccardo Valdagni, Alessandro Magli, E. Moretti, Domenico Cante, Fernando Munoz, P. Ferrari, B. Noris Chiorda, A. Faiella, Elisabetta Garibaldi, Giuseppe Sanguineti, N. Di Muzio, Cristina Piva, Cesare Cozzarini, L. Ferella, V. Vavassori, Marco Gatti, Giuseppe Girelli, Claudio Fiorino, Barbara Avuzzi, Tiziana Rancati, and A. Bresolin

Subjects
medicine.medical_specialty, Prostate cancer, Oncology, business.industry, Urology, Medicine, Radiology, Nuclear Medicine and imaging, Urinary incontinence, Hematology, medicine.symptom, business, medicine.disease
Published
2021
Full Text
View/download PDF

26. PO-1563 A dose-escalation for early-regression based ART for rectal cancer: a planning feasibility study

Author

Najla Slim, Sara Broggi, Paola Mangili, Claudio Fiorino, A. Del Vecchio, Paolo Passoni, A. Cicchetti, and N. Di Muzio

Subjects
Oncology, medicine.medical_specialty, Colorectal cancer, business.industry, Internal medicine, medicine, Dose escalation, Radiology, Nuclear Medicine and imaging, Hematology, medicine.disease, business, Regression
Published
2021
Full Text
View/download PDF

27. PO-1131 Primary tumors observed in 1325 consecutive breast cancer patients treated with whole breast RT

Author

Chiara Lucrezia Deantoni, Flavia Zerbetto, A.M. Deli, M.S. Di Serio, Andrei Fodor, Claudio Fiorino, Sara Broggi, Paola Mangili, Barbara Longobardi, A. Del Vecchio, Italo Dell'Oca, Roberta Castriconi, Pier Giorgio Esposito, R. Tummineri, N. Di Muzio, Chiara Brombin, and M. Pasetti

Subjects
Oncology, medicine.medical_specialty, Breast cancer, business.industry, Internal medicine, Medicine, Radiology, Nuclear Medicine and imaging, Hematology, Whole breast, business, medicine.disease
Published
2021
Full Text
View/download PDF

28. PD-0747 Knowledge-based approach for DVH prediction in robotic spine SBRT

Author

N. Di Muzio, Chiara Lucrezia Deantoni, Paola Mangili, Alessia Tudda, Sara Broggi, A. Del Vecchio, Lucia Perna, Andrei Fodor, Claudio Fiorino, Roberta Castriconi, and Barbara Longobardi

Subjects
Spine (zoology), medicine.medical_specialty, Oncology, business.industry, medicine, Radiology, Nuclear Medicine and imaging, Hematology, Radiology, business
Published
2021
Full Text
View/download PDF

29. PD-0910 Radical radiotherapy in lymph node or bone metastatic prostate cancer: a single institution series

Author

Roberta Castriconi, Andrei Fodor, Claudio Fiorino, N. Di Muzio, S. Baroni, Sergio Villa, G. Mandurino, Chiara Lucrezia Deantoni, A. Sanchez Galvan, Cesare Cozzarini, R. Tummineri, and P. Pacifico

Subjects
Series (stratigraphy), medicine.medical_specialty, business.industry, Radical radiotherapy, Hematology, medicine.disease, Prostate cancer, medicine.anatomical_structure, Oncology, Medicine, Radiology, Nuclear Medicine and imaging, Radiology, Single institution, business, Lymph node
Published
2021
Full Text
View/download PDF

30. PD-0782 Predicting bRFS after salvage post-prostatectomy RT with a 'one-size-fits-all' TCP-based formula

Author

B. Noris Chiorda, Fernando Munoz, Alessandro Magli, A. Pastorino, Barbara Avuzzi, E. Olivetta, Marco Signor, Giuseppe Sanguineti, Riccardo Valdagni, N. Di Muzio, M. Olivieri, Chiara Lucrezia Deantoni, Andrei Fodor, Claudio Fiorino, Domenico Cante, Sara Broggi, A. Faiella, Tiziana Rancati, L. Ferella, Cesare Cozzarini, and Cristina Piva

Subjects
medicine.medical_specialty, Oncology, business.industry, Urology, medicine, Radiology, Nuclear Medicine and imaging, Hematology, business, Post prostatectomy
Published
2021
Full Text
View/download PDF

31. PO-1212 Outcome of adjuvant hypofractionated radiotherapy concomitant to chemotherapy in bile duct carcinoma

Author

L. Aldrighetti, N. Di Muzio, Monica Ronzoni, A. Casadei Gardini, F. Pedica, F. De Cobelli, P. Pacifico, Paolo Passoni, Claudio Fiorino, Stefano Cascinu, A.M. Deli, Najla Slim, and R. Tummineri

Subjects
Hypofractionated Radiotherapy, medicine.medical_specialty, Chemotherapy, business.industry, medicine.medical_treatment, Urology, Hematology, Bile Duct Carcinoma, Oncology, Concomitant, Medicine, Radiology, Nuclear Medicine and imaging, business, Adjuvant
Published
2021
Full Text
View/download PDF

32. PH-0108 New dose-volume constraints for patient-reported acute bowel toxicity symptoms in whole pelvis IMRT

Author

Claudio Fiorino, J.M. Waskiewicz, Elisabetta Garibaldi, B. Noris Chiorda, V. Vavassori, N. Di Muzio, Riccardo Valdagni, A. Bresolin, Tiziana Rancati, Carla Sini, A. Faiella, Barbara Avuzzi, G. Girellli, Angelo Maggio, Cesare Cozzarini, Alessandro Magli, Eugenio Villa, Valeria Landoni, L. Ferella, Fernando Munoz, Giuseppe Sanguineti, Domenico Cante, S. Aimonetto, and Marco Gatti

Subjects
medicine.medical_specialty, Oncology, business.industry, Toxicity, medicine, Radiology, Nuclear Medicine and imaging, Hematology, Radiology, Whole-Pelvis, Dose volume constraints, business
Published
2021
Full Text
View/download PDF

34. Comparison of salvage radiation therapy delivered for PSA persistence versus PSA relapse after radical prostatectomy: How is the outcome changing?

Author

Alberto Bossi, G. De Meerleer, Thomas Wiegel, B. Noris Chiorda, Simone Scuderi, Elio Mazzone, S.F. Shariat, G. Gandaglia, Charlien Berghen, N. Di Muzio, Stephen A. Boorjian, Gregor Goldner, A. Briganti, Robert Jeffrey Karnes, Giovanni Motterle, S. Joniau, Daniele Robesti, Carlo Andrea Bravi, Cesare Cozzarini, F. Montorsi, T. Kumar, N. Fossati, Armando Stabile, H. Van Poppel, and Detlef Bartkowiak

Subjects
Oncology, medicine.medical_specialty, Salvage radiation, business.industry, Prostatectomy, Urology, Internal medicine, medicine.medical_treatment, Medicine, business, Outcome (game theory), Psa relapse, Persistence (computer science)
Published
2021
Full Text
View/download PDF

35. There is no way to compensate a non-timely use of early salvage radiation therapy in men with recurrent Prostate Cancer after Radical Prostatectomy. A retrospective, multi-centre analyses on oncological and toxicity outcomes

Author

Gregor Goldner, Giovanni Motterle, Alberto Bossi, S.F. Shariat, G. Gandaglia, Thomas Wiegel, G. De Meerleer, T. Kumar, N. Fossati, F. Montorsi, S.A. Boorjan, B. Noris Chiorda, N. Di Muzio, Cesare Cozzarini, Detlef Bartkowiak, Armando Stabile, S. Joniau, H. Van Poppel, Simone Scuderi, Robert Jeffrey Karnes, Elio Mazzone, Charlien Berghen, and A. Briganti

Subjects
Oncology, medicine.medical_specialty, Salvage radiation, business.industry, Prostatectomy, Urology, Internal medicine, medicine.medical_treatment, Toxicity, Medicine, Recurrent prostate cancer, Multi centre, business
Published
2021
Full Text
View/download PDF

36. Very long-term outcomes, time patterns of recurrence and other-cause mortality in patients treated with salvage radiation therapy for recurrent prostate cancer after radical prostatectomy: Implications for risk tailored follow-up strategies

Author

Alberto Martini, N. Fossati, F. Montorsi, S.A. Boorjan, G. Gandaglia, G. De Meerleer, Elio Mazzone, A. Briganti, Thomas Wiegel, Armando Stabile, Charlien Berghen, S.F. Shariat, Detlef Bartkowiak, Gaëtan Devos, Gregor Goldner, S. Joniau, Andrea Necchi, H. Van Poppel, Dirk Böhmer, Cesare Cozzarini, Alberto Bossi, N. Di Muzio, and Robert Jeffrey Karnes

Subjects
Oncology, medicine.medical_specialty, business.industry, Prostatectomy, Urology, medicine.medical_treatment, Time pattern, Salvage radiation, Internal medicine, medicine, Long term outcomes, In patient, Recurrent prostate cancer, business
Published
2021
Full Text
View/download PDF

37. The role of 68Ga-PSMA-11 PET/CT in restaging high risk prostate cancer patients with PSA persistence after surgery

Author

A. Farolfi, E. Balestrazzi, Alessio G. Morganti, Riccardo Mei, Eugenio Brunocilla, F. Farneti, L.C. Bianchi, N. Di Muzio, F. Montorsi, Paolo Castellucci, Riccardo Schiavina, S. Fanti, Cesare Cozzarini, A. Ercolino, Matteo Droghetti, F. Mattana, F. Cicognani, F. Medici, and A. Briganti

Subjects
Persistence (psychology), Oncology, medicine.medical_specialty, PET-CT, Prostate cancer, business.industry, Urology, Internal medicine, medicine, business, medicine.disease, 68Ga-PSMA-11
Published
2021
Full Text
View/download PDF

38. PO-0915: Clinical Activation Of An Efficient Low-Dose Total Body Irradiation Using The Tomodirect Approach

Author

Fabio Ciceri, Riccardo Calandrino, G. Salvadori, S. Selli, S. Piemontese, Andrea Assanelli, Sara Broggi, Claudio Fiorino, Jacopo Peccatori, N. Di Muzio, Anna Chiara, and M. Pasetti

Subjects
Oncology, Chemistry, business.industry, Low dose, Radiology, Nuclear Medicine and imaging, Hematology, Total body irradiation, Nuclear medicine, business
Published
2020
Full Text
View/download PDF

40. PD-0668: Longitudinal analysis of patient-reported urinary incontinence 2yr after post-prostatectomy RT

Author

Pietro Gabriele, Elisabetta Garibaldi, Barbara Noris Chiorda, Claudio Fiorino, N. Di Muzio, Tiziana Rancati, A. Bresolin, Giuseppe Girelli, Domenico Cante, Eugenio Villa, Riccardo Valdagni, Barbara Avuzzi, V. Vavassori, Cesare Cozzarini, Alessandro Magli, Giuseppe Sanguineti, A. Faiella, J.M. Waskiewicz, Fernando Munoz, and Marco Gatti

Subjects
medicine.medical_specialty, Oncology, business.industry, Urology, medicine, Radiology, Nuclear Medicine and imaging, Urinary incontinence, Hematology, medicine.symptom, business, Post prostatectomy
Published
2020
Full Text
View/download PDF

41. PH-0366: Predictors of incontinence 2yr after post-prostatectomy RT: evidence of dose & fractionation effects

Author

Marco Gatti, A. Bresolin, Tiziana Rancati, Eugenio Villa, Riccardo Valdagni, Barbara Avuzzi, Giuseppe Sanguineti, V. Vavassori, Barbara Noris Chiorda, Pietro Gabriele, Claudio Fiorino, Domenico Cante, Fernando Munoz, Elisabetta Garibaldi, N. Di Muzio, J.M. Waskiewicz, A. Faiella, Giuseppe Girelli, Alessandro Magli, and Cesare Cozzarini

Subjects
medicine.medical_specialty, Oncology, business.industry, Urology, medicine, Dose fractionation, Radiology, Nuclear Medicine and imaging, Hematology, business, Post prostatectomy
Published
2020
Full Text
View/download PDF

42. PD-0539: Chemo-modulation of rectal cancer pathological response: prediction of an early regression index

Author

Sara Broggi, Riccardo Rosati, Paolo Passoni, M. Mori, Giovanni Mauro Cattaneo, Najla Slim, N. Di Muzio, Anna Palmisano, Monica Ronzoni, Claudio Fiorino, F. De Cobelli, Riccardo Calandrino, C. Gumina, and A. Di Chiara

Subjects
Oncology, medicine.medical_specialty, Index (economics), business.industry, Colorectal cancer, Pathological response, Hematology, medicine.disease, Regression, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, business
Published
2020
Full Text
View/download PDF

43. PH-0717: Locally Advanced Pancreatic Cancer: Robust Radiomic based model of outcome after radiochemotherapy

Author

N. Di Muzio, Emilia Giovanna Vanoli, Sara Broggi, M. Mori, Michele Reni, Paolo Passoni, Claudio Fiorino, Maria Picchio, Elena Incerti, Giovanni Mauro Cattaneo, L. Gianolli, Emiliano Spezi, Valentino Bettinardi, and Najla Slim

Subjects
Oncology, medicine.medical_specialty, business.industry, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, Hematology, business, Outcome (game theory), Locally advanced pancreatic cancer
Published
2020
Full Text
View/download PDF

44. PD-0059: Patient-reported baseline incontinence at post-prostatectomy RT: its dependence on time from surgery

Author

J.M. Waskiewicz, A. Faiella, A. Bresolin, Domenico Cante, Giuseppe Girelli, Elisabetta Garibaldi, Giuseppe Sanguineti, Tiziana Rancati, Fernando Munoz, Alessandro Magli, Barbara Noris Chiorda, N. Di Muzio, Riccardo Valdagni, Eugenio Villa, Barbara Avuzzi, Marco Gatti, V. Vavassori, Cesare Cozzarini, Pietro Gabriele, and Claudio Fiorino

Subjects
medicine.medical_specialty, Oncology, business.industry, medicine, Radiology, Nuclear Medicine and imaging, Hematology, Baseline (configuration management), business, Post prostatectomy, Surgery
Published
2020
Full Text
View/download PDF

46. COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy

Author

Laura Fariselli, Barbara Alicja Jereczek-Fossa, C. Italia, Stefano Bracelli, M. Amadori, Gianpiero Catalano, L.F. Cazzaniga, Francesco Stiglich, Giancarlo Beltramo, S. Castiglioni, Fabrizio Lombardi, Giovanni Ivaldi, S. Tonoli, Roberto Tortini, Simonetta Nava, Stefano Arcangeli, Elena Lara Sbicego, Paolo Antognoni, Stefano Maria Magrini, Riccardo Valdagni, Giulia Marvaso, Luciano Scandolaro, Mario Bignardi, S. Berlinghieri, Lorenza Bruschieri, Ester Orlandi, A. Gramaglia, Nadia Pasinetti, Matteo Pepa, Marta Scorsetti, V. Vavassori, Alberto Buffoli, Andrea Riccardo Filippi, N. Di Muzio, Mauro Palazzi, Carlo Pietro Soatti, Carlo Fallai, Jereczek-Fossa, B, Palazzi, M, Soatti, C, Cazzaniga, L, Ivaldi, G, Pepa, M, Amadori, M, Antognoni, P, Arcangeli, S, Buffoli, A, Beltramo, G, Berlinghieri, S, Bignardi, M, Bracelli, S, Bruschieri, L, Castiglioni, S, Catalano, G, Di Muzio, N, Fallai, C, Fariselli, L, Filippi, A, Gramaglia, A, Italia, C, Lombardi, F, Magrini, S, Nava, S, Orlandi, E, Pasinetti, N, Sbicego, E, Scandolaro, L, Scorsetti, M, Stiglich, F, Tonoli, S, Tortini, R, Valdagni, R, Vavassori, V, Marvaso, G, Jereczek-Fossa, B. A., Palazzi, M. F., Soatti, C. P., Cazzaniga, L. F., Ivaldi, G. B., Pepa, M., Amadori, M., Antognoni, P., Arcangeli, S., Buffoli, A., Beltramo, G., Berlinghieri, S., Bignardi, M., Bracelli, S., Bruschieri, L., Castiglioni, S., Catalano, G., Di Muzio, N., Fallai, C., Fariselli, L., Filippi, A. R., Gramaglia, A., Italia, C., Lombardi, F., Magrini, S. M., Nava, S., Orlandi, E., Pasinetti, N., Sbicego, E. L., Scandolaro, L., Scorsetti, M., Stiglich, F., Tonoli, S., Tortini, R., Valdagni, R., Vavassori, V., and Marvaso, G.

Subjects
2019-20 coronavirus outbreak, Medical staff, Infectious Disease Transmission, Patient-to-Professional, Coronavirus disease 2019 (COVID-19), Pneumonia, Viral, Betacoronavirus, Environmental health, Neoplasms, Medicine, Humans, Covid-19, Radiotherapy, Radiology, Nuclear Medicine and imaging, Pandemics, Infection Control, business.industry, SARS-CoV-2, Outbreak, COVID-19, Northern italy, Oncology, Italy, Radiology Nuclear Medicine and imaging, Treatment interruption, Cancer Radiotherapy, Practice Guidelines as Topic, business, Coronavirus Infections
Published
2020

47. 43. TCP approach to predict the pathological response based on MRI-based quantification of early tumor regression in rectal cancer neo-adjuvant radio-chemotherapy

Author

Sara Broggi, Giovanni Mauro Cattaneo, M. Mori, A. Di Chiara, N. Di Muzio, Najla Slim, Anna Palmisano, Riccardo Calandrino, Claudio Fiorino, F. De Cobelli, R. Raso, Paolo Passoni, and C. Gumina

Subjects
Oncology, medicine.medical_specialty, business.industry, Colorectal cancer, Biophysics, General Physics and Astronomy, Pathological response, General Medicine, Neo adjuvant, medicine.disease, Internal medicine, Tumor regression, Medicine, Radiology, Nuclear Medicine and imaging, business, Radio chemotherapy
Published
2018
Full Text
View/download PDF

48. PO-1308 Image-guided helical/volumetric IMRT in vulvar cancer: results of a mono-institutional experience

Author

S. Baroni, Andrei Fodor, Chiara Lucrezia Deantoni, Paola Mangili, S.L. Villa, A. Del Vecchio, G. Mandurino, N. Di Muzio, R. Tummineri, Flavia Zerbetto, A. Sanchez Galvan, and P. Pacifico

Subjects
medicine.medical_specialty, Oncology, business.industry, medicine, Radiology, Nuclear Medicine and imaging, Hematology, Radiology, Vulvar cancer, medicine.disease, business
Published
2021
Full Text
View/download PDF

50. PO-1300 Stereotactic Body Radiation Therapy for oligometastatic lymph-nodal relapses in gynecological cancer

Author

S. Baroni, Paola Mangili, G. Mandurino, A. Del Vecchio, A. Sanchez Galvan, Chiara Lucrezia Deantoni, N. Di Muzio, S.L. Villa, Flavia Zerbetto, P. Pacifico, R. Tummineri, Andrei Fodor, and Stefano Arcangeli

Subjects
medicine.medical_specialty, Oncology, business.industry, Stereotactic body radiation therapy, medicine, Radiology, Nuclear Medicine and imaging, Hematology, Radiology, Lymph, NODAL, business, Gynecological cancer
Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results